RAYMOND C. STEVENS, PHD

Corporate Board Profile

Tech Score: 83/100

← Back to All Directors

Software Technology Evidence

5 mention(s) identify RAYMOND C. STEVENS, PHD as having software/technology expertise.

Company Filing Date Evidence Reason
DANAHER CORP /DE/ 2020-03-25 Professor Stevens is considered among the world’s most influential biomedical scientists in molecular research. A professor and CEO of a biotechnology company with extensive experience in molecular research, indicating strong technical skills.
DANAHER CORP /DE/ 2021-03-25 Professor Stevens is considered among the world’s most influential biomedical scientists in molecular research. Has extensive experience in molecular research and biotechnology, indicating strong technical skills related to software in research contexts.
DANAHER CORP /DE/ 2022-03-30 Chief Executive Officer, ShouTi Professor and CEO of a biotechnology company, involved in drug discovery and molecular research, indicating strong technical skills.
DANAHER CORP /DE/ 2023-03-29 Professor Stevens has served as Chief Executive Officer of Structure Therapeutics. Extensive experience in molecular research and biotechnology, indicating familiarity with technology and software in a scientific context.
DANAHER CORP /DE/ 2024-03-27 Professor Stevens is considered among the world’s most influential biomedical scientists in molecular research. Expert in molecular research and biotechnology, indicating strong technical skills.

DANAHER CORP /DE/

Filing Date Source Excerpt
2020-03-25 Professor Stevens is considered among the world’s most influential biomedical scientists in molecular research.
2021-03-25 Professor Stevens is considered among the world’s most influential biomedical scientists in molecular research.
2022-03-30 Chief Executive Officer, ShouTi
2023-03-29 Professor Stevens has served as Chief Executive Officer of Structure Therapeutics.
2024-03-27 Professor Stevens is considered among the world’s most influential biomedical scientists in molecular research.
2025-03-26 Professor Stevens is considered among the world’s most influential biomedical scientists in molecular research.

Data sourced from SEC filings. Last updated: 2025-07-01